Fuji Pharma Co., Ltd. (TYO:4554)
2,244.00
+12.00 (0.54%)
May 8, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 57.64 billion as of May 8, 2026. Its market cap has increased by 87.86% in one year.
Market Cap
57.64B
Enterprise Value
84.72B
Revenue
54.57B
Ranking
n/a
PE Ratio
23.50
Stock Price
2,244.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 57.64B, an increase of 231.55%. That is a compound annual growth rate of 6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 57.64B | 24.83% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 181.15B |
| Kaken Pharmaceutical | 152.61B |
| Mochida Pharmaceutical | 120.71B |
| Zeria Pharmaceutical | 92.41B |
| KYORIN Pharmaceutical | 89.04B |
| ASKA Pharmaceutical Holdings | 83.29B |
| Koa Shoji Holdings | 37.19B |
| Daito Pharmaceutical | 35.33B |